Core Viewpoint - Kefu Medical's stock price has declined, closing at 44.13 yuan with a drop of 2.73%, currently in a state of breaking issue [1] Group 1: Company Overview - Kefu Medical submitted an application for the issuance of overseas listed foreign shares (H shares) to the Hong Kong Stock Exchange on August 29, 2025 [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext board on October 25, 2021, with an initial public offering of 40 million shares at a price of 93.09 yuan per share [1] - The highest price recorded for Kefu Medical's stock was 95.00 yuan on October 26, 2021, the day after its listing [1] Group 2: Financial Highlights - Kefu Medical raised a total of 3.724 billion yuan from its initial public offering, with a net amount of 3.527 billion yuan after deducting issuance costs [1] - The final net fundraising amount exceeded the original plan by 2.52 billion yuan, which was initially set at 1.007 billion yuan for various projects including the construction of a health monitoring and medical care product production base [1] - The total issuance costs for the IPO amounted to 197 million yuan, with underwriting and sponsorship fees accounting for 174 million yuan [2] Group 3: Shareholder Returns - In 2021, Kefu Medical announced a dividend distribution plan, distributing 16.00 yuan in cash for every 10 shares and a capital reserve increase of 3.00 shares for every 10 shares held [2] - The total share capital increased from 160,375,000 shares to 208,487,500 shares following the dividend distribution [2]

Core Points - The stock price of Kefu Medical (301087.SZ) has dropped by 4.35%, closing at 43.71 yuan, currently in a state of decline [1] - Kefu Medical submitted an application for overseas listing (H shares) on August 29, 2025, to the Hong Kong Stock Exchange [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext board on October 25, 2021, with an initial public offering (IPO) of 40 million shares at a price of 93.09 yuan per share [1] Fundraising and Financials - Kefu Medical raised a total of 3.724 billion yuan from its IPO, with a net amount of 3.527 billion yuan after deducting issuance costs, exceeding the original plan by 2.52 billion yuan [2] - The funds raised are allocated for the construction of a smart health monitoring and medical care product production base, an intelligent medical industrial park, a research and development center, and working capital [2] - The total issuance costs amounted to 197 million yuan, with underwriting and sponsorship fees of 174 million yuan [3] Dividend Distribution - In 2021, Kefu Medical announced a dividend distribution plan, distributing 16.00 yuan in cash for every 10 shares and a capital reserve increase of 3.00 shares for every 10 shares held [3] - The total share capital increased from 160,375,000 shares to 208,487,500 shares following the dividend distribution [3]